Paeoniflorin regulates microglia-astrocyte crosstalk, inhibits inflammatory response, and alleviates neuropathic pain through HSP90AA1/HMGB1 signaling pathway
Authors:
- 11 October 2024
- journal article
- research article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 176, 106675
Abstract
No abstract availableKeywords
Funding Information
- Department of Health of Zhejiang Province (2023KY852)
This publication has 40 references indexed in Scilit:
- HMGB1: A New Target for Ischemic Stroke and Hemorrhagic TransformationTranslational Stroke Research, 2024
- Review on pharmacological effects of gastrodinArchives of Pharmacal Research, 2023
- An exploratory study on the mechanism of Huangqi Guizhi Wuwu Decoction in the treatment of neuropathic painIbrain, 2022
- Salidroside Alleviates Chronic Constriction Injury-Induced Neuropathic Pain and Inhibits of TXNIP/NLRP3 PathwayNeurochemical Research, 2021
- Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neuronsBrain, Behavior, and Immunity, 2020
- Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancerBiomedicine & Pharmacotherapy, 2020
- Baicalin prevents the up‐regulation of TRPV1 in dorsal root ganglion and attenuates chronic neuropathic painVeterinary Medicine and Science, 2020
- Paeoniflorin attenuates chronic constriction injury-induced neuropathic pain by suppressing spinal NLRP3 inflammasome activationInflammopharmacology, 2020
- Induction of suppressor of cytokine signaling 3 via HSF-1-HSP70-TLR4 axis attenuates neuroinflammation and ameliorates postoperative painBrain, Behavior, and Immunity, 2018
- Paeoniflorin attenuates Aβ1-42-induced inflammation and chemotaxis of microglia in vitro and inhibits NF-κB- and VEGF/Flt-1 signaling pathwaysBrain Research, 2015